Analyst Insight: In today's unpredictable pharmaceutical business climate, supply chains must be synchronized to deliver adequate supply to capture new sales while reducing costs. This is a classic case of balancing risk and opportunity, whereby synchronization allows all required parties to operate in a coordinated and flexible manner resulting in seamless delivery to the customers. Getting this right can drive millions of dollars in value, and there are ways to do this today. - Jay Welsh, principal, Ernest & Young LLP, and Srihari Rangarajan, manager, Ernst & Young LLP

Analyst Insight: Drug Supply Chain Security Act (DSCSA) requirements for serialization, verification and traceability are driving investments in distribution. But leaders are looking beyond compliance for real ROI and competitive advantage. They are looking at different applications and new technologies that enable compliance and allow the business the flexibility to scale with increasing return on additional investment. - Roger Counihan, life sciences industry leader, Fortna Inc.

Analyst Insight: The 2016 DC Measures Study from the Warehousing Education and Research Council shows over 35 percent of respondents report to the C-suite, where interest in logistics performance will only increase. To better communicate to the C-suite, logistics needs to focus on managing and monitoring their performance by concentrating on the three pillars of performance management. In order to be successful, we must think beyond simple short-term results and move towards a better model for managing performance. - Joe Tillman, principal research lead for supply chain, APQC